We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

CT UK Growth & Income Class Z - Income (GBP)

Sell:183.63p Buy:183.63p Change: 2.57p (1.38%)
Prices as at 28 May 2026
Sell:183.63p
Buy:183.63p
Change: 2.57p (1.38%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 28 May 2026
Sell:183.63p
Buy:183.63p
Change: 2.57p (1.38%)
Prices as at 28 May 2026
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Asset Allocation

X-ray asset allocation
Key % Net Assets
UK Equities 89.28%
Property 6.10%
International Equities 3.75%
Cash and Equiv. 0.87%

Top 10 holdings

Stock name % Weight Country Sector
1 GSK 6.66% GBR Pharmaceuticals & Biotechnology
2 UNILEVER 4.99% GBR Personal Care, Drug & Grocery Stores
3 IMPERIAL BRANDS 4.62% GBR Tobacco
4 PEARSON 4.59% GBR Media
5 CENTRICA 3.81% GBR Gas, Water & Multi-utilities
6 ITV 3.75% GBR Media
7 BT GROUP 3.70% GBR Telecommunications Service Providers
8 RENTOKIL INITIAL 3.57% GBR Industrial Support Services
9 QUILTER 3.50% GBR Investment Banking & Brokerage Services
10 ASTRAZENECA 3.16% GBR Pharmaceuticals & Biotechnology

Fund Analysis is only available on the desktop version of our website. This can be accessed using a desktop or laptop PC or some larger tablets.

You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account